Blennow K - Search Results

1

Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.

Shahim P, Darin N, Andreasson U, Blennow K, Jennions E, Lundgren J, Månsson JE, Naess K, Törnhage CJ, Zetterberg H, Mattsson N. Shahim P, et al. Among authors: blennow k. Pediatr Neurol. 2013 Jul;49(1):31-39.e2. doi: 10.1016/j.pediatrneurol.2013.02.015. Pediatr Neurol. 2013. PMID: 23827424

2

Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Månsson JE, Svennerholm L. Blennow K, et al. Aging (Milano). 1992 Dec;4(4):301-6. Aging (Milano). 1992. PMID: 1294245

3

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Månsson JE, Svennerholm L. Blennow K, et al. Arch Neurol. 1991 Oct;48(10):1032-5. doi: 10.1001/archneur.1991.00530220048018. Arch Neurol. 1991. PMID: 1929894

4

Parenteral administration of GM1 ganglioside to presenile Alzheimer patients.

Svennerholm L, Gottfries CG, Blennow K, Fredman P, Karlsson I, Månsson JE, Toffano G, Wallin A. Svennerholm L, et al. Among authors: blennow k. Acta Neurol Scand. 1990 Jan;81(1):48-53. doi: 10.1111/j.1600-0404.1990.tb00930.x. Acta Neurol Scand. 1990. PMID: 2330815

5

Cerebrospinal fluid 'neuronal thread protein' comes from serum by passage over the blood-brain barrier.

Blennow K, Wallin A, Chong JK. Blennow K, et al. Neurodegeneration. 1995 Jun;4(2):187-93. doi: 10.1006/neur.1995.0023. Neurodegeneration. 1995. PMID: 7583683

6

Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.

Blennow K, Wallin A, Gottfries CG, Månsson JE, Svennerholm L. Blennow K, et al. J Neural Transm Park Dis Dement Sect. 1993;5(1):5-15. doi: 10.1007/BF02260910. J Neural Transm Park Dis Dement Sect. 1993. PMID: 7679905

7

Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.

Blennow K, Wallin A, Gottfries CG, Karlsson I, Månsson JE, Skoog I, Wikkelsö C, Svennerholm L. Blennow K, et al. Eur Neuropsychopharmacol. 1993 Mar;3(1):55-61. doi: 10.1016/0924-977x(93)90295-w. Eur Neuropsychopharmacol. 1993. PMID: 7682460

8

Immunomodulating and anti-inflammatory properties of the sympatholytic compound 6-hydroxydopamine.

Josefsson E, Månsson JE, Blennow K, Tarkowski A. Josefsson E, et al. Among authors: blennow k. J Neuroimmunol. 1994 Dec;55(2):161-9. doi: 10.1016/0165-5728(94)90006-x. J Neuroimmunol. 1994. PMID: 7829666

9

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L. Blennow K, et al. Int Psychogeriatr. 1994 Spring;6(1):13-22; discussion 59-60. doi: 10.1017/s1041610294001584. Int Psychogeriatr. 1994. PMID: 8054491

10

Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.

Blennow K, Fredman P, Wallin A, Gottfries CG, Långström G, Svennerholm L. Blennow K, et al. Eur Neurol. 1993;33(2):126-8. doi: 10.1159/000116918. Eur Neurol. 1993. PMID: 8467818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,211 results

Search Page

Filters